FDA
approval
· 2018-06-29
FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
Summary
FDA approved the original application for Triamterene and Hydrochlorothiazide from Zydus Pharmaceuticals (USA) Inc., a generic fixed-dose combination diuretic.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TRIAMTERENE AND HYDROCHLOROTHIAZIDE (TRIAMTERENE AND HYDROCHLOROTHIAZIDE)